...
首页> 外文期刊>BioMetals: An International Journal on the Role of Metal Ions in Biology, Biochemistry and Medicine >Environmental epidemiological study and estimation of benchmark dose for renal dysfunction in a cadmium-polluted area in China
【24h】

Environmental epidemiological study and estimation of benchmark dose for renal dysfunction in a cadmium-polluted area in China

机译:中国镉污染地区肾脏功能障碍的环境流行病学研究和基准剂量估算

获取原文
获取原文并翻译 | 示例
           

摘要

We have performed a study aimed at investigating the critical concentration of urinary cadmium (UCd) required for the development of renal dysfunction. We studied population groups (totally 790 persons) living in two cadmium exposed areas and one control area in China. UCd, was determined as an indicator of cadmium exposure and accumulation, while the concentrations of N-acetyl-beta-D-glucosaminidase (NAG), its iso-form B (NAG-B), beta2-microglobulin (B2M), retinol binding protein (RBP), and albumin (ALB) in urine were measured as indicators of the renal effects caused by cadmium. There was a significantly increased prevalence of hyperNAGuria, hyperNAGBuria, hyperB2Muria, hyperRBPuria and hyperALBuria with increasing levels of Cd excretion in urine. We used the benchmark dose (BMD) procedure to estimate the critical concentration of urinary cadmium in this general population. The lower confidence limit of the BMD (LBMD-05) of urinary cadmium for a 5% level of risk above the background level was estimated for each of the renal effect indicators. The BMD-05/LBMD-05 were estimated to be 4.46/3.99, 6.70/5.87, 8.36/7.31, 7.98/6.98 and 15.06/12.18 mug/g creatinine for urinary NAG-B, NAG, B2M, RBP and ALB, respectively. Our findings suggest, based on the present study, that the Lower Confidence Limit of the Population Critical Concentration of UCd (LPCCUCd-05) of tubular dysfunction for 5% excess risk level above the background may be ca. 3-4 mug/g creatinine, and that cadmium concentration in urine should be kept below this level to prevent renal tubular damage. This report is the first to use the BMD method in this field and to define the concept of critical concentration in urine.
机译:我们进行了一项研究,旨在研究肾功能不全所必需的临界浓度的尿镉(UCd)。我们研究了居住在中国两个镉暴露地区和一个控制地区的人口群体(总共790人)。 UCd被确定为镉暴露和积累的指标,而N-乙酰-β-D-氨基葡萄糖苷酶(NAG),其同型B(NAG-B),β2-微球蛋白(B2M),视黄醇结合的浓度测定尿中的蛋白质(RBP)和白蛋白(ALB)作为镉引起的肾功能的指标。随着尿液中Cd排泄量的增加,hyperNAGuria,hyperNAGBuria,hyperB2Muria,hyperRBPuria和hyperALBuria的患病率显着增加。我们使用基准剂量(BMD)程序来估算该一般人群中尿镉的临界浓度。对于每项肾效应指标,估计了高于背景水平5%的风险水平时,尿镉的BMD(LBMD-05)的置信下限。尿NAG-B,NAG,B2M,RBP和ALB的BMD-05 / LBMD-05估计分别为4.46 / 3.99、6.70 / 5.87、8.36 / 7.31、7.98 / 6.98和15.06 / 12.18杯/克肌酐。 。根据本研究,我们的发现表明,在高于背景水平5%的危险水平下,肾小管功能障碍的UCd人口临界浓度(LPCCUCd-05)的下限可信度可能为。 3-4马克/克肌酐,尿中的镉浓度应保持在此水平以下,以防止肾小管损伤。该报告是首次在该领域使用BMD方法并定义尿液中临界浓度的概念。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号